SwePub
Sök i LIBRIS databas

  Utökad sökning

(WFRF:(Aasly J))
 

Sökning: (WFRF:(Aasly J)) > Association of LRRK...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00006794naa a2201021 4500
001oai:lup.lub.lu.se:fbe2089e-e2b7-4665-b777-55c99e6906d6
003SwePub
008160401s2011 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:123395582
024a https://lup.lub.lu.se/record/22117072 URI
024a https://doi.org/10.1016/S1474-4422(11)70175-22 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1233955822 URI
040 a (SwePub)lud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Ross, Owen A.4 aut
2451 0a Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study
264 1c 2011
520 a Background The leucine-rich repeat kinase 2 gene (LRRK2) harbours highly penetrant mutations that are linked to familial parkinsonism. However, the extent of its polymorphic variability in relation to risk of Parkinson's disease (PD) has not been assessed systematically. We therefore assessed the frequency of LRRK2 exonic variants in individuals with and without PD, to investigate the role of the variants in PD susceptibility. Methods LRRK2 was genotyped in patients with PD and controls from three series (white, Asian, and Arab-Berber) from sites participating in the Genetic Epidemiology of Parkinson's Disease Consortium. Genotyping was done for exonic variants of LRRK2 that were identified through searches of literature and the personal communications of consortium members. Associations with PD were assessed by use of logistic regression models. For variants that had a minor allele frequency of 0.5% or greater, single variant associations were assessed, whereas for rarer variants information was collapsed across variants. Findings 121 exonic LRRK2 variants were assessed in 15 540 individuals: 6995 white patients with PD and 5595 controls, 1376 Asian patients and 962 controls, and 240 Arab-Berber patients and 372 controls. After exclusion of carriers of known pathogenic mutations, new independent risk associations were identified for polymorphic variants in white individuals (M1646T, odds ratio 1.43, 95% CI 1.15-1.78; p=0.0012) and Asian individuals (A419V, 2.27, 1.35-3.83; p=0.0011). A protective haplotype (N551K-R1398H-K1423K) was noted at a frequency greater than 5% in the white and Asian series, with a similar finding in the Arab-Berber series (combined odds ratio 0.82, 0.72-0.94; p=0.0043). Of the two previously reported Asian risk variants, G2385R was associated with disease (1.73, 1.20-2.49; p=0.0026), but no association was noted for R1628P (0.62, 0.36-1.07; p=0.087). In the Arab-Berber series, Y2189C showed potential evidence of risk association with PD (4.48, 133-15.09; p=0.012). Interpretation The results for LRRK2 show that several rare and common genetic variants in the same gene can have independent effects on disease risk. LRRK2, and the pathway in which it functions, is important in the cause and pathogenesis of PD in a greater proportion of patients with this disease than previously believed. These results will help discriminate those patients who will benefit most from therapies targeted at LRRK2 pathogenic activity. Funding Michael J Fox Foundation and National Institutes of Health.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng
700a Soto-Ortolaza, Alexandra I.4 aut
700a Heckman, Michael G.4 aut
700a Aasly, Jan O.4 aut
700a Abahuni, Nadine4 aut
700a Annesi, Grazia4 aut
700a Bacon, Justin A.4 aut
700a Bardien, Soraya4 aut
700a Bozi, Maria4 aut
700a Brice, Alexis4 aut
700a Brighina, Laura4 aut
700a Van Broeckhoven, Christine4 aut
700a Carr, Jonathan4 aut
700a Chartier-Harlin, Marie-Christine4 aut
700a Dardiotis, Efthimios4 aut
700a Dickson, Dennis W.4 aut
700a Diehl, Nancy N.4 aut
700a Elbaz, Alexis4 aut
700a Ferrarese, Carlo4 aut
700a Ferraris, Alessandro4 aut
700a Fiske, Brian4 aut
700a Gibson, J. Mark4 aut
700a Gibson, Rachel4 aut
700a Hadjigeorgiou, Georgios M.4 aut
700a Hattori, Nobutaka4 aut
700a Ioannidis, John P. A.4 aut
700a Jasinska-Myga, Barbara4 aut
700a Jeon, Beom S.4 aut
700a Kim, Yun Joong4 aut
700a Klein, Christine4 aut
700a Kruger, Rejko4 aut
700a Kyratzi, Elli4 aut
700a Lesage, Suzanne4 aut
700a Lin, Chin-Hsien4 aut
700a Lynch, Timothy4 aut
700a Maraganore, Demetrius M.4 aut
700a Mellick, George D.4 aut
700a Mutez, Eugenie4 aut
700a Nilsson, Christeru Lund University,Lunds universitet,Psykiatri, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Psychiatry (Lund),Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)neur-cni
700a Opala, Grzegorz4 aut
700a Park, Sung Sup4 aut
700a Puschmann, Andreasu Lund University,Lunds universitet,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Klinisk neurogenetik,Forskargrupper vid Lunds universitet,Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine,Clinical Neurogenetics,Lund University Research Groups4 aut0 (Swepub:lu)med-aps
700a Quattrone, Aldo4 aut
700a Sharma, Manu4 aut
700a Silburn, Peter A.4 aut
700a Sohn, Young Ho4 aut
700a Stefanis, Leonidas4 aut
700a Tadic, Vera4 aut
700a Theuns, Jessie4 aut
700a Tomiyama, Hiroyuki4 aut
700a Uitti, Ryan J.4 aut
700a Valente, Enza Maria4 aut
700a van de Loo, Simone4 aut
700a Vassilatis, Demetrios K.4 aut
700a Vilarino-Gueell, Cartes4 aut
700a White, Linda R.4 aut
700a Wirdefeldt, Karinu Karolinska Institutet4 aut
700a Wszolek, Zbigniew K.4 aut
700a Wu, Ruey-Meei4 aut
700a Farrer, Matthew J.4 aut
710a Psykiatri, Lundb Sektion IV4 org
773t Lancet Neurologyg 10:10, s. 898-908q 10:10<898-908x 1474-4465
856u http://dx.doi.org/10.1016/S1474-4422(11)70175-2y FULLTEXT
8564 8u https://lup.lub.lu.se/record/2211707
8564 8u https://doi.org/10.1016/S1474-4422(11)70175-2
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:123395582

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy